In Vivo

@INVIVOnow

In Vivo is the premier strategic business resource for the biopharma, medtech, and diagnostics industries.

Vrijeme pridruživanja: siječanj 2014.

Tweetovi

Blokirali ste korisnika/cu @INVIVOnow

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @INVIVOnow

  1. prije 10 sati

    New Business Models Are Needed To Support Innovative Payer Partnerships Maximizing patient access to innovative and effective treatments will require increased transparency, improved outcomes data analyses, dynamic contract management and...

    Poništi
  2. prije 11 sati

    Global Biopharma R&D Productivity And Growth Ranking An analysis of the R&D productivity of the world’s 30 largest public pharmaceutical companies reveals an overall drop in R&D... Related Stories In Vivo's Rough Guide On The State Of RNAi

    Poništi
  3. prije 13 sati

    Partnerships in will help advance medicines but who do you think should take home the top spot in the 12th annual Contest? Click here to vote for the top Alliance Deal:

    Poništi
  4. 4. velj

    Discover new opportunities for success with partnering with the industry experts that leaders trust and rely on. Click to download your media kit here

    Poništi
  5. 3. velj

    Who do you think deserves to win the for M&A? ✅ Roche/Spark ✅ AbbVie/Allergan ✅ Bristol-Meyers-Squibb/Celgene ✅ 3M/Acelity ✅ Sumitomo Dainippon/Five Roivant Sciences Divisions Caste your vote here:

    Poništi
  6. 3. velj

    In Vivo's Rough Guide On The State Of RNAi The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold... Related Stories 2019’s Top Biopharma Deal-Makers Deals

    Poništi
  7. 30. sij

    Wondering how you will fill your pipeline & hit your sales numbers in 2020? By partnering with , you can generate high quality leads, fill your pipeline & create bespoke . Find out more here

    Poništi
  8. 30. sij

    It is that time of year again! It is time to vote in the 12th annual contest! We have chosen 15 nominees across 3 categories: Financing, M&A & Alliance. Caste your vote here

    Poništi
  9. 29. sij

    Did you get your entry in for the 2020 ? Have you seen our illustrious judging panel who will choosing the finalists & winners! Take a look here to read more

    Poništi
  10. 27. sij

    Our packages offer unique marketing opportunities, ranging from category sponsorship to the prestigious headline sponsor. Find out how you can cement your position in the clinical R&D sector

    Poništi
  11. 23. sij

    C-Suite Snippets: US Generics Industry Under Pressure In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo. Related Stories Execs On The Move, January 2020 In Vivo's Top M&A Of

    Poništi
  12. 23. sij

    CNS Biomarkers: Monument Targets Schizophrenia, Anxiety And Cognitive Decline Steven Powell, chair of the board at Cambridge Cognition, talks about the group’s latest spin-off company, Monument Therapeutics. Related Stories Connected

    Poništi
  13. 22. sij

    Connected Strategies Are Vital For Medtechs In The Consumer-Led 2020s Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the... Related Stories Internal Manufacturing

    Poništi
  14. 22. sij

    ESG In 2020: Not A Tick-Box Exercise But A Strategic Opportunity The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure... Related Stories Bayer US

    Poništi
  15. 20. sij

    ENTRY DEADLINE EXTENSION! Missed Friday's entry deadline for the 2020 ? We have extended the entry deadline for the 2020 until Friday January 24th 2020! Don't miss out and get your entries in now!

    Poništi
  16. 20. sij

    Internal Manufacturing Capabilities Are Critical To Level-Up eTheRNA A year into his role as a CEO of the Belgian mRNA biotech eTheRNA immunotherapies, industry veteran Steven Powell talks... Related Stories C-Suite Snippets: Meindert

    Poništi
  17. 20. sij

    Execs On The Move, January 2020 An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries. Related Stories In Vivo's Top M&A Of 2019: Cast Your Vote! In Vivo's

    Poništi
  18. 16. sij

    In Vivo's Top M&A Of 2019: Cast Your Vote! It is time for In Vivo's 12th annual Deals of the Year contest. We've selected 15 nominees in three categories... Related Stories In Vivo's Top Financing Of 2019: Cast Your Vote! When Will POC

    Poništi
  19. 16. sij

    In Vivo's , includes new chapters on strategy & and what they mean for the and industries. Click to download your copy here and delve into the future:

    Poništi
  20. 15. sij

    When Will POC Really Be On The Cusp Of Major Uptake? Point-of-care/near-patient testing has been “two years away from major breakthrough” for at least two decades, but fast access to data... Related Stories In Vivo's Top Alliance Of 2019:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·